E. Oleneva, P. Ryvkin, and M. Ladyzhensky, “Paliperidone Palmitate 3-Month Formulation (Trevicta) – a new word for the longterm therapy of patients with schizophrenia”, СТПР, no. 1, pp. 35–43, Mar. 2017.